An international study led by VHIO within the ENIGMA consortium has analysed 166 variants in and around exon 18 of…
Hereditary Cancer Genetics Group
Professionals from the Hereditary Cancer Genetics Group at Vall d’Hebron Institute of Oncology (VHIO), led by Dr. Judith Balmaña, participated…
The Hereditary Cancer Unit of the Medical Oncology Department at Vall d’Hebron University Hospital and the Hereditary Cancer Genetics Group…
As every year, the Endavant Chic@s Association organises numerous recreational and sports activities to raise funds for breast cancer research…
Promoted by SOLTI and developed in scientific collaboration with the Vall d’Hebron Institute of Oncology (VHIO), the SOLTI-1910 RADIOLA study…
Published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), results of a VHIO-led study…
The analysis of homologous recombination DNA repair in primary breast and ovarian tumours in patients with pathogenic germline variants in…
The Breast Cancer Research Foundation (BCRF) will commit $60.2 million to breast cancer research in 2023-2024, supporting more than 250…
An International Workgroup of Cancer Genetics Experts Convened by the American College of Medical Genetics and Genomics Develops Guidance on…
The RADPrecise project young investigators team, coordinated by Ester Aguado Flor from the VHIO Hereditary Cancer Genetics Group, has won…
